Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GALR3 | O60755 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 4/20 | 0.37 |
| ▸ | MEN1 | O00255 | 3/20 | 0.37 |
| ▸ | TSHR | P16473 | 2/20 | 0.37 |
| ▸ | HTT | P42858 | 2/20 | 0.37 |
| ▸ | MAPK1 | P28482 | 1/20 | 0.37 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.37 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.37 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.37 |
| ▸ | MAPT | P10636 | 3/20 | 0.36 |
| ▸ | PTK2 | Q05397 | 1/20 | 0.35 |
| ▸ | MTNR1A | P48039 | 1/20 | 0.34 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.34 |
| ▸ | TAS1R3 | Q7RTX0 | 1/20 | 0.34 |
| ▸ | TAS1R1 | Q7RTX1 | 1/20 | 0.34 |
| ▸ | NR2F2 | P24468 | 1/20 | 0.34 |
| ▸ | AKR1C3 | P42330 | 2/20 | 0.33 |
| ▸ | NPC1 | O15118 | 1/20 | 0.33 |
| ▸ | RAB9A | P51151 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL29652519 | 1.00 | GALR3 (0.38) | GALR3KMT2AMEN1TSHRHTT | |
| SCHEMBL31605552 | 0.93 | MAPT (0.38) | GALR3KMT2AMEN1TSHRHTT | |
| SCHEMBL21596821 | 0.93 | MAPT (0.38) | GALR3KMT2AMEN1TSHRHTT | |
| SCHEMBL21596809 | 0.86 | MAPT (0.36) | KMT2AMEN1TSHRHTTMAPK1 | |
| SCHEMBL29652454 | 0.86 | MAPT (0.36) | KMT2AMEN1TSHRHTTMAPK1 | |
| SCHEMBL29652522 | 0.84 | ALDH1A1 (0.32) | KMT2AMEN1TSHRHTTMAPK1 | |
| SCHEMBL28906747 | 0.84 | ALDH1A1 (0.32) | KMT2AMEN1TSHRHTTMAPK1 | |
| SCHEMBL28507830 | 0.84 | KAT7 (0.33) | KMT2AMEN1TSHRHTTMAPK1 | |
| SCHEMBL29652540 | 0.84 | KAT7 (0.33) | KMT2AMEN1TSHRHTTMAPK1 | |
| SCHEMBL28512950 | 0.80 | CCNA2 (0.36) | KDM4E |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260062393-A1 | Compounds | CTXT PTY LTD (AU) | 2026-03-05 | — | — | US | disclosed |
| US-12365655-B2 | Compounds | CTXT PTY LTD (AU) | 2025-07-22 | — | — | US | disclosed |
| EP-4335439-A2 | COMPOUNDS | CTXT PTY LTD (AU) | 2024-03-13 | — | — | EP | disclosed |
| US-20220153710-A1 | Compounds | CTXT PTY LTD (AU) | 2022-05-19 | — | — | US | disclosed |
| EP-3810602-A1 | COMPOUNDS | CTXT Pty Limited (AU) | 2021-04-28 | — | — | EP | disclosed |
| US-20200039945-A1 | Compounds | CTXT PTY LIMITED (AU) | 2020-02-06 | — | — | US | disclosed |
| WO-2019243491-A1 | COMPOUNDS | CTXT PTY LIMITED (AU) | 2019-12-26 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220153710-A1 | Compounds | SLC10A1, ABCB11, PCSK9 | GALR3 3288/4885KMT2A 4165/4885MEN1 122/4885 |
| US-20200039945-A1 | Compounds | SLC10A1, ABCB11, PCSK9 | GALR3 3282/4885KMT2A 4165/4885MEN1 121/4885 |
| US-20260062393-A1 | Compounds | SCN2B, ABCB11, SCN1B | GALR3 926/4885KMT2A 890/4885MEN1 866/4885 |
| US-12365655-B2 | Compounds | SLC10A1, ABCB11, PCSK9 | GALR3 3282/4885KMT2A 4165/4885MEN1 121/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.